| Name | Title | Contact Details |
|---|
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
APLUS INSTITUTE is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
INTEGRIS Health is Oklahoma's largest privately owned health system.
Toniiq (pronounced "tonic") is the answer to the ineffective and bland hangover treatments available today. It is made exclusively from a single natural ingredient, and unlike other products, does not contain dozens of additives or fillers. Our obsessi...
Trans Life Ambulance is a Van Nuys, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.